{"url_path":"/sec/envb/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/890821/0001493152-26-023345-index.html","accession_number":"0001493152-26-023345","cik":"0000890821","ticker":"ENVB","issuer_name":"Enveric Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/890821/0001493152-26-023345-index.html","primary_entity_key":"0000890821","primary_entity_name":"Enveric Biosciences, Inc."},"word_count":80,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit**\n\n**Number**\n\n \n**Description**\n\n \n \n \n\n99.1\n \n[Press Release, dated May 15, 2026 (furnished pursuant to Item 2.02)](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nMay 15, 2026\n**ENVERIC\nBIOSCIENCES, INC.**\n\n \n \n \n\n \nBy:\n*/s/\nJoseph Tucker*\n\n \n \nJoseph\nTucker\n\n \n \nChief\nExecutive Officer"}